Minnesota Academy of Family Physicians
MARCH 27, 2025
As we move into the tenth week of the legislative session, Minnesota Academy of Family Physicians (MAFP) lobbyist Megan Verdeja breaks down what’s happening at the Minnesota State Capitol and provides an update on health care bills. The bill passed by a voice vote and was referred to the State and Local Government Committee.
FDA Law
JANUARY 15, 2024
Koblitz — You know a court decision is going to be worth reading when the judges compare FDA’s regulatory governance of flavored e-cigarettes to a Shakespearean gaslighting. FDA extended PMTA compliance deadlines for years so it could figure out appropriate application instructions and so that manufacturers could figure out how to comply.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Georgetown Pediatrics & Family Medicine
MAY 11, 2022
Always mix formula as directed by the manufacturer. I heard the government will be importing baby formula from other countries. The post Baby Formula Shortages appeared first on Georgetown Pediatrics & Family Medicine. Always follow label instructions or those given to you by your pediatrician. Is that safe?
FDA Law
AUGUST 23, 2021
Kirschenbaum — On August 6, 2021, the Pharmaceutical Research and Manufacturers of America (PhRMA) announced the release of a revised PhRMA Code on Interactions with Health Care Professionals , which takes effect on January 1, 2022. not friends, significant others, or family members of a speaker or invitee). By McKenzie E.
Health One Family Medicine
APRIL 30, 2021
The laws governing the skincare and cosmetics industry are very limited. As with parabens, manufacturers add them to reduce the risk of bacterial contamination. Be Smart With Your Beauty Products At Health One Family Medicine , we always place more emphasis on overall wellness, since a healthy body will automatically look beautiful.
The Health Policy Exchange
MAY 20, 2013
Food and Drug Administration to market a new drug is a critical waypoint along the path to profits for pharmaceutical manufacturers. In the meantime, lobbyists working for the drug manufacturers successfully blocked efforts by Medicare administrators to stop paying for the higher (harmful) doses. Approval from the U.S. Phillips, Jr.
GeriPal
MARCH 2, 2023
And for that reason, there was actually an enormous lawsuit, and the manufacturer was fined, now I think 20 years ago, in the millions and millions of dollars for off-label prescribing. These are families who are in distress. We should be able to trust all the data that comes from our governing board.
Expert insights. Personalized for you.
52 
Let's personalize your content